NASDAQ:ORIAU

Orion Biotech Opportunities Corp. Units Stock Forecast, Price & News

$10.14
+0.02 (+0.20 %)
(As of 06/18/2021 03:45 AM ET)
Add
Compare
Today's Range
$10.14
$10.14
50-Day Range N/A
52-Week Range
$9.95
$10.85
Volume40,700 shs
Average Volume100,627 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ORIAU News and Ratings via Email

Sign-up to receive the latest news and ratings for Orion Biotech Opportunities Corp. Units and its competitors with MarketBeat's FREE daily newsletter.


About Orion Biotech Opportunities Corp. Units

Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.00 out of 5 stars

Financial Services Sector

484th out of 621 stocks

Shell Companies Industry

94th out of 199 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Orion Biotech Opportunities Corp. Units (NASDAQ:ORIAU) Frequently Asked Questions

What stocks does MarketBeat like better than Orion Biotech Opportunities Corp. Units?

Wall Street analysts have given Orion Biotech Opportunities Corp. Units a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Orion Biotech Opportunities Corp. Units wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Orion Biotech Opportunities Corp. Units' key executives?

Orion Biotech Opportunities Corp. Units' management team includes the following people:
  • Mr. Zuie-Chin Huang M.B.A., CEO & Director (Age 55)
  • Mr. Mark Kayal, CFO & Sec.
  • Mr. Robert Kenneth Simonds, Gen. Counsel, Assistant Sec., VP & Director

Who are some of Orion Biotech Opportunities Corp. Units' key competitors?

When did Orion Biotech Opportunities Corp. Units IPO?

(ORIAU) raised $200 million in an IPO on Thursday, May 13th 2021. The company issued 20,000,000 shares at $10.00 per share. Cantor acted as the underwriter for the IPO.

What is Orion Biotech Opportunities Corp. Units' stock symbol?

Orion Biotech Opportunities Corp. Units trades on the NASDAQ under the ticker symbol "ORIAU."

When does Orion Biotech Opportunities Corp. Units' quiet period expire?

Orion Biotech Opportunities Corp. Units' quiet period expires on Tuesday, June 22nd. Orion Biotech Opportunities Corp. Units had issued 20,000,000 shares in its public offering on May 13th. The total size of the offering was $200,000,000 based on an initial share price of $10.00. During Orion Biotech Opportunities Corp. Units' quiet period, underwriters and any insiders involved in the IPO are restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Orion Biotech Opportunities Corp. Units?

Shares of ORIAU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Orion Biotech Opportunities Corp. Units' stock price today?

One share of ORIAU stock can currently be purchased for approximately $10.14.

How can I contact Orion Biotech Opportunities Corp. Units?

The company can be reached via phone at 213-303-1650.


This page was last updated on 6/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.